|
Format - PDF file
|
Catalent Pharma Solutions is one of the leading providers of advanced dose form and packaging technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies around the world. |
09-Jun-2008 - Sartorius Stedim Biotech has teamed up with Wuxi AppTec to help companies remove some of the strain of carrying out viral clearance testing, which for large biopharmaceutical companies can carry a price tag of up to $1m a year.
26-May-2008 - Catalent Pharma Solutions has reported a profit drop in its latest financial results, completed the sale of one of its businesses, and is undergoing regulatory scrutiny over the overall control and management of quality systems at one of its sterile facilities.
09-Apr-2008 - Stiefel Laboratories, Biopharm Services, Multisorb Technologies, the Pharmaceutical Research and Manufacturers of America, Catalent Pharma Solutions and Chromatide have all had people on the move in the world of pharmaceutical manufacturing.
31-Jan-2008 - US contract manufacturer Catalent Pharma Solutions has leveraged its partnership with Secure Symbology (SSI) for track and trace barcode technology to help biopharmaceutical company Biogen Idec comply with California's pending ePedigree law.
29-Jan-2008 - Unexpected contract downturns have resulted in Catalent Pharma Solutions having to lay off 100 workers at its soft gelatin capsules facility in St Petersburg, Florida.
31-Oct-2007 - There are lessons to be learned about the importance of rigorous due diligence of pharma contractors, now that Inyx' customers are facing possible supply issues and a scramble to find alternative manufacturers after the firm's collapse.
29-Oct-2007 - Novavax, Cobra Biomanufacturing, Catalent Pharma Solutions, and Suven Life Sciences have all recently announced new contract manufacturing news.
20-Sep-2007 - Catalent Pharma Solutions, the firm born from the spin out of Cardinal Health's contract manufacturing business, is reorganising its production facilities with an expansion of its UK site and the divestiture of some of its French operations.
29-Aug-2007 - ALK-Abello will be funding a new DKK 300m (€40.3m) production line dedicated to its oral grass pollen allergy vaccine at Catalent Pharma Solutions' UK facility.
02-Aug-2007 - In a round-up of motley pharmaceutical services news, Outsourcing-Pharma takes a look at recent announcements involving Quintiles, Kenexa, Atos, Catalent Pharma, Patni and Taratec.